ArticleBMC urology2012

Docetaxel with or without estramustine for estramustine refractory castration-resistant prostate cancer: a single institution experience.

Kazuhiko Nakano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.